Semisynthesis of 22,25-Epoxylanostane Triterpenoids: Structure Revision and Protective Effects against Oxygen-Glucose Deprivation/Reoxygenation Injury in H9c2 Cells
Journal of Natural Products · 2023
DOI: 10.1021/acs.jnatprod.2c01029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Products, 2023. Verfasst von Yuantao Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, People's…. Hauptthemen laut MEDLINE: Oxygen, Triterpenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
22,25-Epoxylanostane triterpenoids indicated protective effects against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced myocardial injury in a previous study. In order to discover potent cardioprotective agents, 20 22,25-epoxylanostane triterpenoids, including inonotsuoxides A and B, ganodercochlearins A and B, were synthesized from inotodiol (1). The structures of inonotsuoxide B and ganodercochlearin A are revised as 22R,25-epoxylanosta-8-en-3β,24R-diol (6) and 22S,25-epoxylanosta-7,9(11)-dien-3β,24R-diol (12) respectively, based on synthesis, spectroscopic data analysis, and X-ray crystallography. Compounds 13-16 and 22 showed potential protective activity against OGD/R-induced injury in H9c2 cells at a concentration of 20 μM. After OGD/R treatment, the most active compounds 13 and 22 at 5 μM increased cell viability by 11.4% and 6.4% respectively, whereas the positive control diazoxide was 14.9% at 100 μM. Flow cytometric analysis and JC-1 staining assay revealed that 13 suppressed OGD/R-induced apoptosis and the mitochondrial membrane potential in H9c2 cells. Compound 13 may serve as a potential lead cardioprotective agent for further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, People's Republic of China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, People's Republic of China.
ORCID-Profile: Yuanyuan Cheng, Li-Wen Tian
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Han, Y., Cheng, Y., & Tian, L. W. (2023). Semisynthesis of 22,25-Epoxylanostane Triterpenoids: Structure Revision and Protective Effects against Oxygen-Glucose Deprivation/Reoxygenation Injury in H9c2 Cells. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.2c01029
Vancouver
Han Y, Cheng Y, Tian LW. Semisynthesis of 22,25-Epoxylanostane Triterpenoids: Structure Revision and Protective Effects against Oxygen-Glucose Deprivation/Reoxygenation Injury in H9c2 Cells. Journal of Natural Products. 2023. doi:10.1021/acs.jnatprod.2c01029
BibTeX
@article{Han2023,
author = {Han, Yuantao and Cheng, Yuanyuan and Tian, Li-Wen},
title = {Semisynthesis of 22,25-Epoxylanostane Triterpenoids: Structure Revision and Protective Effects against Oxygen-Glucose Deprivation/Reoxygenation Injury in H9c2 Cells},
journal = {Journal of Natural Products},
year = {2023},
doi = {10.1021/acs.jnatprod.2c01029}
}
EUVIMED